A detailed history of Crescent Grove Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Crescent Grove Advisors, LLC holds 4,647 shares of JNJ stock, worth $674,047. This represents 0.08% of its overall portfolio holdings.

Number of Shares
4,647
Previous 5,029 7.6%
Holding current value
$674,047
Previous $735,000 2.45%
% of portfolio
0.08%
Previous 0.08%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$145.48 - $167.38 $55,573 - $63,939
-382 Reduced 7.6%
4,647 $753,000
Q2 2024

Jul 22, 2024

SELL
$144.38 - $157.78 $64,826 - $70,843
-449 Reduced 8.2%
5,029 $735,000
Q1 2024

Apr 29, 2024

SELL
$155.22 - $162.74 $172,138 - $180,478
-1,109 Reduced 16.84%
5,478 $866,000
Q4 2023

Jan 30, 2024

SELL
$145.6 - $158.88 $40,913 - $44,645
-281 Reduced 4.09%
6,587 $1.03 Million
Q3 2023

Oct 25, 2023

BUY
$155.75 - $174.48 $16,665 - $18,669
107 Added 1.58%
6,868 $1.07 Million
Q2 2023

Jul 13, 2023

SELL
$154.35 - $166.11 $61,276 - $65,945
-397 Reduced 5.55%
6,761 $1.12 Million
Q1 2023

May 03, 2023

BUY
$151.05 - $180.26 $16,766 - $20,008
111 Added 1.58%
7,158 $1.11 Million
Q4 2022

Jan 12, 2023

SELL
$160.2 - $179.79 $17,782 - $19,956
-111 Reduced 1.55%
7,047 $0
Q3 2022

Nov 08, 2022

BUY
$161.33 - $179.52 $313,625 - $348,986
1,944 Added 37.28%
7,158 $1.17 Million
Q2 2022

Jul 20, 2022

SELL
$168.19 - $186.01 $45,411 - $50,222
-270 Reduced 4.92%
5,214 $925,000
Q1 2022

May 04, 2022

SELL
$158.14 - $179.59 $238,791 - $271,180
-1,510 Reduced 21.59%
5,484 $972,000
Q4 2021

Jan 24, 2022

BUY
$155.93 - $173.01 $73,754 - $81,833
473 Added 7.25%
6,994 $1.2 Million
Q3 2021

Oct 26, 2021

BUY
$161.5 - $179.47 $173,451 - $192,750
1,074 Added 19.72%
6,521 $1.05 Million
Q2 2021

Jul 26, 2021

BUY
$159.48 - $171.07 $21,051 - $22,581
132 Added 2.48%
5,447 $897,000
Q1 2021

May 07, 2021

BUY
$153.07 - $170.48 $64,595 - $71,942
422 Added 8.62%
5,315 $873,000
Q4 2020

Feb 01, 2021

BUY
$137.11 - $157.38 $6,855 - $7,869
50 Added 1.03%
4,893 $770,000
Q3 2020

Nov 06, 2020

SELL
$140.38 - $153.83 $6,457 - $7,076
-46 Reduced 0.94%
4,843 $721,000
Q2 2020

Aug 03, 2020

SELL
$128.81 - $155.51 $12,752 - $15,395
-99 Reduced 1.98%
4,889 $687,000
Q1 2020

Apr 27, 2020

BUY
$111.14 - $153.99 $10,447 - $14,475
94 Added 1.92%
4,988 $654,000
Q4 2019

Feb 03, 2020

BUY
$127.5 - $146.44 $127 - $146
1 Added 0.02%
4,894 $714,000
Q2 2019

Aug 06, 2019

BUY
$131.15 - $144.24 $22,164 - $24,376
169 Added 3.58%
4,893 $681,000
Q1 2019

May 13, 2019

SELL
$125.72 - $139.79 $247,416 - $275,106
-1,968 Reduced 29.41%
4,724 $660,000
Q4 2018

Jan 29, 2019

BUY
$122.84 - $147.84 $2,211 - $2,661
18 Added 0.27%
6,692 $864,000
Q3 2018

Nov 05, 2018

BUY
$121.58 - $142.88 $121 - $142
1 Added 0.01%
6,674 $922,000
Q1 2018

May 03, 2018

BUY
$125.1 - $148.14 $27,772 - $32,887
222 Added 3.44%
6,673 $855,000
Q4 2017

Feb 06, 2018

SELL
$131.22 - $143.62 $24,275 - $26,569
-185 Reduced 2.79%
6,451 $901,000
Q3 2017

Nov 06, 2017

BUY
$129.47 - $135.38 $859,162 - $898,381
6,636
6,636 $863,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Crescent Grove Advisors, LLC Portfolio

Follow Crescent Grove Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crescent Grove Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crescent Grove Advisors, LLC with notifications on news.